Long-chain acyl-CoA synthetase 1 (ACSL1) contributes more than 90% of total cardiac ACSL activity, but its role in phospholipid synthesis has not been determined. Mice with an inducible knockout of ACSL1 (Acsl1
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Here we show that ACSL1, which has a distinct preference for linoleate, significantly contributes to CL remodeling. Because fatty acids must be converted to acyl-CoAs, both to be available for the initial steps in the synthesis of phospholipids, as well as to enter the mitochondrial matrix where CL remodeling occurs, we asked whether ACSL1 might be responsible for activating linoleate destined to be incorporated into CL.
We found that hearts lacking ACSL1 are deficient in tetralinoleoyl-CL, but that normalizing the CL species cannot ameliorate the mitochondrial dysfunction present in these hearts. These findings call into question the idea that the acyl-chains of CL are important for cardiac and mitochondrial respiratory function.
Materials and Methods
Animal care and diets: All protocols were approved by the Institutional Animal Care and Use Committee at University of North Carolina at Chapel Hill. Mice were group housed under a 12 h light/dark cycle with free access to food and water. Unless otherwise specified, mice were fed a purified low-fat diet (Research Diets, DB12451B). A multi-tissue knockout of ACSL1 was achieved by mating mice with loxP sequences flanking exon one of the Acsl1 gene to animals expressing a tamoxifen-inducible Cre driven by a ubiquitous promoter enhancer (2) . Between six and eight weeks of age, Acsl1
T-/-and littermate control Acsl1 flox/flox (control) mice were injected intraperitoneally on four consecutive days with 20 mg/mL (75 μg/g body weight) tamoxifen dissolved in corn oil. All studies were performed 20 weeks after tamoxifen was injected, unless otherwise specified. Cardiac echocardiography was performed (blinded to mouse type) on conscious mice using a VisualSonics Vevo 770 or Vevo 2100 ultrasound biomicroscopy system (VisualSonics, Inc.).
A model 707B (30 MHz) or model MS-550D (22-55 MHz) scan head was used on the Vevo 770 and Vevo 2100, respectively, as previously described (14) . Two-dimensional guided M-mode echocardiography was performed in the parasternal long-axis view at the level of the papillary muscle on loosely restrained conscious mice. Wall thickness was then determined by measurements of epicardial to endocardial leading edges. For the diet study, group-housed mice were fed a high-linoleate safflower oil diet (Research Diets, D02062104, 45% kcal fat (75% linoleate)) for 4 weeks and were weighed weekly.
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Briefly, homogenized tissues were centrifuged at 100,000 x g for 1 h at 4°C to isolate total membrane fractions. Between 1 and 6 µg of protein was incubated with 50 µM [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]fatty acid (unless otherwise indicated), 10 mM ATP, 250 μM CoA, 5 mM dithiothreitol, and 8 mM MgCl2 in 175 mM Tris, pH 7.4 at RT° for 10 min. The enzyme reaction was stopped with 1 mL of Dole's solution (heptane:isopropanol:1M H2SO4; 80:20:1; v/v). Two mL of heptane and 0.5 ml of water were added to separate phases. Radioactivity of the acyl-CoAs in the aqueous phase was measured using a liquid scintillation counter.
Mitochondrial function studies:
Mitochondrial function was measured in permeabilized myofibers and in isolated mitochondria prepared from portions of the left ventricle and septum. After dissection, muscle samples were placed in ice-cold (4C) Buffer X containing (in mM): 7. The rate of ATP production within the permeabilized myofibers was continuously recorded alongside the O2 consumption in real time, by monitoring the increasing fluorescence in the respiration chamber coming from NADPH (340ex/460em) with a spectrofluorometer, as described (15) . To maintain this reaction, 2.5 U/mL of glucose-6-phosphate dehydrogenase (Roche), 2.5 U/mL yeast hexokinase (Roche), 5 mM nicotinamide adenine dinucleotide phosphate (NADP + ) (Sigma-Aldrich), and 5 mM D-glucose (SigmaAldrich) were added to the assay media. P1,P5-Di(adenosine-5')pentaphosphate (Ap5A) (Sigma-Aldrich) was included in the respiration medium to inhibit adenylate kinase and to ensure that ATP production was solely due to mitochondrial oxidative phosphorylation. An absolute amount of ATP generated across a given time frame was then calculated using a standard curve of fixed concentrations of ATP added to the saturating amounts of hexokinase, glucose, G6PDH, and NADP + . Mitochondrial H2O2 emission was detected using Amplex UltraRed reagent (Invitrogen) in the presence of 1 U/mL horseradish peroxidase and 25 U/mL superoxide dismutase. The rate of H2O2 produced from the mitochondrial electron transport system supported by 125 µM palmitoyl-L-carnitine, 5 mM glutamate, and 5 mM succinate oxidation was determined in permeabilized fibers with 100 µM ADP, 5 mM glucose, and 1 U/mL hexokinase present to maintain the mitochondria in a permanent, submaximal phosphorylating state.
To isolate mitochondria, hearts were minced in 0.125 mg/mL trypsin in homogenization buffer (0.25 M sucrose, 10 mM HEPES, 1 mM EDTA, pH 7.4). Soybean trypsin inhibitor (0.65 mg/mL) was added, and tissues were homogenized and centrifuged at 500 x g for 5 min to remove nuclei and unbroken cells.
Mitochondria were isolated by centrifuging at 10,000 x g for 15 min and washed twice with homogenization buffer. Calcium uptake was measured in Buffer Z, using 1 µM Calcium Green 5-N with 1 µM thapsigargin (Sigma-Aldrich) added to inhibit SERCA, a calcium transport ATPase. In separate experiments, the function of isolated mitochondria was assessed using a Seahorse XF24 Analyzer. Mitochondria (15 µg protein) were stimulated sequentially with 100 µM ADP, 1.26 µM oligomycin, 4 µM FCCP, and 4 µm antimycin A (Sigma-Aldrich). Liquid chromatography/mass spectrometry: For normal phase separation, samples were injected onto an Ascentis-Si HPLC column (150 x 2.1 mm, 5 µm; Supelco) at a flow rate of 0.2 ml/min with 25% solvent B and 75% solvent A. Solvent B was maintained at 25% for 5 min, increased to 60% over 10 min, and then to 95% over 5 min. The system was held at 95% Solvent B for 20 min before re-equilibration at 25% for 14 min. Phospholipids were measured using an API3200 triple quadrupole mass spectrometer (AB Sciex). Cell lipids were extracted and phospholipids were separated by thin layer chromatography as described above. protein and ACSL specific activity were enriched in the mitochondrial fraction, compared to whole tissue (Fig. 1A, B) . Purified recombinant ACSL1 from rat liver shows a broad fatty acid substrate preference with varying chain lengths and degrees of unsaturation (19) . To determine the fatty acid substrate preference in mouse heart, long-chain acyl-CoA synthetase (ACSL) activity was assayed with different fatty acid substrates in total membrane preparations from control and Acsl1 T-/-hearts. Control hearts exhibited the highest ACSL activity with linoleate (18:2) (Fig. 1C) . This clear substrate preference was lost in Acsl1 T-/-hearts, which lack more than 90% of total ACSL activity with all fatty acids (Fig. 1D) ,
Microscopy
indicating that the preferential activation of linoleate was due to ACSL1 activity.
Loss of ACSL1 caused mitochondrial dysfunction. Acsl1
T-/-and littermate control mice were injected with tamoxifen at 6-8 weeks to produce ACSL1 deficiency. Ten weeks after tamoxifen injection, Acsl1
T-/-hearts are enlarged but have normal systolic function (2) . To determine whether function worsens with time, echocardiography was performed 20 weeks after initiating the ACSL1 knockout. Acsl1 T-/-hearts remained hypertrophied with no impairment in contractile function ( Fig. 2A, B, C) . To determine whether loss of ACSL1 caused mitochondrial dysfunction, O2 consumption in saponin-permeabilized cardiac muscle fibers was measured using palmitoyl-carnitine and malate (Fig. 2D ) or pyruvate and malate ( Fig.   2E ) with increasing concentrations of ADP or succinate. Basal O2 consumption rate was normal in Acsl1
T-/-mitochondria, but compared to controls, the mitochondrial response to ADP stimulation was 56% lower.
In addition to impaired ADP-stimulated oxygen consumption, Acsl1 T-/-mitochondria produced less ATP for each O2 molecule consumed, indicative of inefficient energy production (Fig. 2F) . Although many models of mitochondrial dysfunction produce increased amounts of H2O2, Acsl1 T-/-mitochondria did not, possibly due to their lower metabolic rate (Fig. 2G) . Isolated Acsl1 T-/-mitochondria took up less calcium than controls before reaching the permeability transition (Fig. 2H) , suggesting that Acsl1 T-/-mitochondria may be more susceptible to stress and apoptosis. Calcium uptake into mitochondria increases oxygen by guest, on November 10, 2017
www.jlr.org Downloaded from consumption and NADH production, but once calcium uptake exceeds the permeability transition, mitochondria are more likely to become disrupted, release cytochrome c into the cytosol, and undergo apoptosis (20) . Despite this severely impaired respiratory function, Acsl1 T-/-mice do not develop heart failure under unstressed conditions (2) and have a normal lifespan (data not shown).
Loss of ACSL1 altered the acyl-chain composition of mitochondrial cardiolipin and phospholipids.
Cardiolipin associates closely with complexes of the electron transport chain and is highly important for mitochondrial function (3, 4) . Cardiac cardiolipin normally contains as much as 77% linoleate (8) . Because ACSL1 has a distinct preference for linoleate, we questioned whether the loss of ACSL1 would affect the composition of cardiolipin and other phospholipids in cardiac mitochondria. The content of individual phospholipid species in cardiac ventricles did not differ between genotypes (Fig. 3A) ; however, in the knockout mice the average chain length and number of double bonds was lower (Fig. 3B, C) . Mass spectrometry analysis revealed that loss of ACSL1 caused large changes in the acyl-chain composition of the major phospholipid species. As has been reported previously (8) , the major cardiolipin (CL) species in control mouse hearts contained four linoleate acyl-chains (tetralinoleoyl-CL; 72:8-CL) (Fig. 3D) . In the
Acsl1
T-/-mitochondria, however, this species was 83% lower, and compared to controls, the CL species containing 2 linoleate and 2 arachidonate acyl chains (76:12-CL) was 80% lower. Acsl1 T-/-heart mitochondria contained larger amounts of CL species esterified with stearate (18:0) and oleate (18:1), indicating either that CL remodeling was impaired or that the availability of linoleate was limited.
To determine whether the loss of ACSL1 impaired linoleate incorporation into other phospholipids, several species were fragmented to identify the acyl chains present. Linoleate-containing species of PC and PE (36:3-PC, 36:2-PC, and 36:2-PE) were approximately 2-to 4-fold higher in Acsl1 T-/-hearts than in controls.
Excess linoleate in these species suggests that the absence of ACSL1, which is primarily located on the mitochondrial outer membrane, altered the incorporation of linoleoyl-CoA into PC and PE which are synthesized and remodeled on the endoplasmic reticulum. Furthermore, the excess linoleate present in by guest, on November 10, 2017
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13 mitochondrial PC and PE was consistent with impaired transacylation from these donor phospholipids.
Compared to controls, the expression of the transacylase tafazzin was 31% lower in Acsl1 T-/-hearts ( Fig.   3H ), suggesting an explanation for both excess linoleate in PC and PE and the diminished tetralinoleoyl-CL (37), although we did not observe the increase in MLCL that is a hallmark of tafazzin deficiency.
Loss of ACSL1 altered other mitochondrial phosphatidylinositol (PI), PC, and PE species (Fig. 3E, F, G) , but no differences were seen in phosphatidylglycerol or phosphatidylserine (data not shown). In control mitochondria, the most abundant mitochondrial PI was 18:0, 20:4-PI. This species was 64% lower in the
Acsl1
T-/-hearts, and was compensated for by a higher content of multiple minor PI species, so that the total content of PI was unchanged in the two genotypes. For PC, the major species in control hearts contained docosahexaenoic acid (DHA; 22:6) together with either palmitate (38:6-PC) or stearate (40:6-PC).
Compared to controls, these species were 53% and 48% lower, respectively, in Acsl1 T-/-hearts. PC species that contained DHA were replaced with oleate in the Acsl1 T-/-mitochondria so that 16:0-18:1-PC (34:1-PC) was 2-fold higher and 18:0-18:1-PC (36:1-PC) was 3-fold higher than in control hearts. The major PE species in control hearts also contained DHA and stearate (40:6-PE) and was approximately 30% lower in the Acsl1 T-/-hearts. Impaired activation of α-linolenate due to loss of ACSL1 at the peroxisomal membrane may result in decreased uptake into peroxisomes where DHA synthesis occurs (21) . The compositions of PC and PE in isolated mitochondria from control and Acsl1 T-/-ventricles were similar to those in total membranes (data not shown), supporting the idea that ACSL1 strongly influences phospholipid synthesis in the endoplasmic reticulum where these phospholipids are synthesized and remodeled (22) .
Knockdown of Acsl1 in H9c2 cardiomyocytes impaired both the oxidation of fatty acid and its incorporation into complex lipids.
To further investigate how the loss of ACSL1 affects phospholipid formation, we made a stable knockdown of Acsl1 in H9c2 cells, a rat cardiomyocyte cell line. The knockdown caused a 67% loss of Acsl1 mRNA, a 55% reduction of ACSL1 protein, and a 26% decrease in total ACSL activity (Fig. 4A, B, C (ASM) in the media, the oxidation of these fatty acids was 80% lower in the Acsl1 knockdown cells than in controls (Fig. 4D) , consistent with the requirement for ACSL1 in channeling long-chain fatty acids into the pathway of β-oxidation (2). Decreased ACSL1 also caused approximately 40% lower incorporation of fatty acids into total glycerolipids (Fig. 4E) .
The ACSL1 knockdown in H9c2 cells greatly diminished incorporation of fatty acids into neutral lipids and PC ( Fig. 4F, H) . The incorporation of linoleate into CL was 32% lower in Acsl1 knockdown cells (Fig   4G) , which is consistent with the low content of tetralinoleoyl-CL in the Acsl1 T-/-hearts. Compared to control cells, the incorporation of palmitate into PC, PE, PS, and CL was lower by 43%, 34%, 17%, and 46%, respectively (Fig. 4H) . Consistent with Acsl1 T-/-hearts, knockdown of ACSL1 resulted in a 57% loss of tafazzin mRNA (data not shown). In contrast to highly oxidative cardiomyocytes in vivo, cultured cells rely minimally on fatty acid oxidation for energy. Thus, compared to heart, in which palmitate is more readily oxidized, cultured cells activate more palmitate destined for esterification into phospholipids. Other than PC in which 37% less oleate was incorporated, no differences in the incorporation of oleate into phospholipids were observed between control and Acsl1 knockdown cells. Thus, in cultured cardiomyocytes, as in liver (23), loss of ACSL1 impaired the activation of fatty acids that were incorporated into TAG and phospholipids, with the largest effects found with palmitate and linoleate.
Overexpressed ACSL1 increased linoleate metabolism. To confirm the dependence of CL remodeling on linoleate that had been activated by ACSL1, ACSL1 was overexpressed in H9c2 cardiomyocytes (Fig.   5A ) where it localized primarily to mitochondria (Fig. 5B) . The Ad-Acsl1 infection increased ACSL specific activity 3.3-fold (Fig. 5C) . After a 6 h incubation with trace amounts of each of the [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]fatty acids, the cells overexpressing ACSL1 increased linoleate oxidation by 28%; but the oxidation of palmitate and oleate did not change (Fig. 5D) . ACSL1 overexpression increased both palmitate and linoleate by guest, on November 10, 2017
www.jlr.org Downloaded from incorporation into total lipids by 17% and 26%, respectively (Fig. 5E) . ACSL1 overexpression increased linoleate incorporation into neutral lipid by 48%, cardiolipin by 28%, PC by 28%, and phosphatidylserine by 22% (Fig. 5F, G, H) . Palmitate incorporation was less influenced by overexpressed ACSL1; its incorporation into PC, PI, and phosphatidylserine increased 17-18%, similar to the 17% increase seen in total lipid incorporation (Fig. 5F) . In contrast to the association of low ACSL1 with diminished tafazzin abundance, ACSL1 overexpression did not raise tafazzin expression (data not shown). In heart and skeletal muscle, which both contain high proportions of tetralinoleoyl-CL (2, 23), the predominance of the ACSL1 isoform may underlie the enrichment in tetralinoleoyl-CL.
ACSL1 overexpression increased linoleate incorporation into CL in HEK-293 cells. To determine
whether the ability of ACSL1 to increase linoleate incorporation into CL was specific to cardiomyocytes, we overexpressed ACSL1 in HEK-293 cells, which normally contain little tetralinoleoyl-CL (24) . Twentyfour h after the Ad-Acsl1 infection, ACSL1 protein was present, and total ACSL specific activity had increased 9-fold (Fig. 6A, B (Fig. 6C) . The Ad-Acsl1 infection did not alter the esterification of these fatty acids into neutral lipids (Fig.   6D) , showing that the differences in total lipid incorporation were due to integration into phospholipids.
ACSL1 overexpression resulted in 41% and 94% higher incorporation of palmitate and linoleate, respectively, into CL, but no difference was observed in oleate incorporation (Fig. 6E) . ACSL1 increased the incorporation of each of the fatty acids into PC, PE, and PI/PS (Fig. 6F) , phospholipids that are synthesized at the endoplasmic reticulum. The high incorporation of labeled fatty acids into these phospholipids is likely due to increased fatty acid uptake and elevated acyl-CoA concentrations in the cytosol, but importantly, ACSL1 specifically increased linoleate incorporation into CL, which is remodeled Importantly, the safflower oil diet increased the tetralinoleoyl-CL content of Acsl1 T-/-hearts to a level that was equal to the content in hearts from control mice fed the low fat diet (Fig. 7A) . Tafazzin expression was not altered by diet, and the normalization of tetralinoleoyl-CL content was not due to increased tafazzin expression, because the expression of this gene remained 25% lower in the safflower oil-fed Acsl1 T-/-mice, compared to controls (Fig. 7B) . To determine the effect of normalized tetralinoleoyl-CL content on mitochondrial respiration, we measured the function of the electron transport chain in isolated mitochondria. Basal O2 consumption did not differ between groups (Fig. 7C) . Similar to the data from permeabilized cardiac fibers, Acsl1 T-/-hearts contained functionally defective mitochondria, as shown by impaired responses to ADP and FCCP (Fig. 7D) . In control mitochondria, safflower feeding increased respiration after oligomycin treatment but did not change the response to ADP or FCCP. However, despite the normalization of tetralinoleoyl-CL content, safflower oil feeding did not improve the respiratory function of mitochondria from Acsl1 T-/-hearts, and responses to both ADP and the mitochondrial uncoupler FCCP remained 30-44% lower than controls (Fig. 7D) .
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Discussion
CL is synthesized and remodeled within the mitochondria, but its precursors, phosphatidic acid and CDPdiacylglycerol, are formed primarily on the endoplasmic reticulum and are imported into the mitochondria where phosphatidylglycerol is synthesized (28) . CL synthase then combines phosphatidylglycerol with the phosphatidyl group from a second molecule of CDP-diacylglycerol. Because CL synthase lacks a preference for phosphatidylglycerol or CDP-diacylglycerol species that contain linoleate (9, 29) , the acylchains of the nascent CL are more highly saturated than those of mature cardiac CL. CL is remodeled by successive removal of acyl-chains by a phospholipase, followed by replacement of the acyl chain via tafazzin-mediated transacylation from donor phospholipids or by an acyltransferase-mediated esterification which requires an acyl-CoA (10).
Although cardiac CL is highly remodeled after synthesis, the functional significance of the remodeling remains unknown. In Saccharomyces cerevisiae lacking tafazzin, an additional deletion of the CL-specific phospholipase, Cld1, prevents the accumulation of MLCL, inhibits CL remodeling, and rescues the mitochondrial respiratory defect, strongly suggesting that the respiratory defect had been due to the accumulation of MLCL and/or the decrease in the total content of CL (25) . In mammalian cells, two additional enzymes, lysocardiolipin acyltransferase 1 (ALCAT1) and MLCL acyltransferase 1 (MLCL AT-1), can use acyl-CoAs to esterify MLCL (28) . ALCAT1, however, is located on the ER, which would prevent its interaction with most CL (30), but MLCL AT-1 is present in mitochondria (11) . Although overexpressing MLCL AT-1 in tafazzin-deficient lymphoblasts increases both linoleate incorporation into CL and total CL content (11), the importance of MLCL AT-1 for normal CL remodeling in heart cells remains unclear.
With its preference for linoleate, ACSL1 appears to be critical in maintaining the abundance of the tetralinoleoyl-CL species in the heart. This might occur in two ways: ACSL1-derived linoleoyl-CoA could be incorporated into donor phospholipids and then transacylated into CL or the linoleoyl-CoA could be directly incorporated into MLCL by an acyltransferase. The mitochondria located ACSL1 could increase the concentration of linoleoyl-CoA that is imported into mitochondria for β-oxidation or CL remodeling. Diminished tafazzin expression in the context of lowered ACSL1 activity remains unexplained. In the heart-specific knockout of Acsl1, remarkable alterations were observed in the expression of genes related to activated mTORC1, but we did not identify tafazzin expression as being significantly reduced (31) . The regulation of tafazzin has not been fully studied, however decreased mRNA expression has been reported with thyroxine treatment (32) which results in an increase in total CL content without favoring the formation of tetralinoleoyl-CL (33) . Heart failure also diminishes both tafazzin expression (34) and tetralinoleoyl-CL content (35), demonstrating a physiological relationship between tafazzin expression and CL species.
However, neither hyperthyroidism nor heart failure was present in the Acsl1 T-/-mice.
Because the composition of the major CL species varies in different tissues, it is highly likely that the species formed depends on the fatty acid preference of the ACSL isoforms present. The substrate preferences originally reported for ACSL1 were investigated with recombinant rat ACSL1 protein purified from bacteria (36) . The differences in substrate preference observed in our study may reflect the presence of cell membranes as well as mammalian post-translational modifications by phosphorylation and acetylation (37) , but additional studies must be performed to confirm this interpretation. The ER-localized ACSL isoforms would dictate which acyl-CoAs are incorporated into PC and PE, and the ACSL isoforms present on the outer mitochondrial membrane may synthesize acyl-CoAs that can be incorporated directly into CL. For instance, ACSL1 accounts for more than 90% of ACSL activity in both heart (2) and skeletal muscle (38) in which more than 75% of CL is tetralinoleoyl-CL (8) . In contrast, tetralinoleoyl-CL is ~50%
of the total CL species in liver (8), a tissue in which ACSL1 is responsible for only about 50% of total ACSL activity (23) . Similarly, ACSL1 is minimally expressed in brain (39) in which the major CL acylchains are oleate and arachidonate (40) . An analysis of the fatty acid preferences of other ACSL isoforms may explain tissue differences in CL composition.
In contrast to tafazzin-deficient mice, Acsl1 T-/-hearts do not contain a low total CL content or excess MLCL.
Thus, the Acsl1 T-/-model allowed us to study CL remodeling in the presence of a normal CL content, as well as the impact of impaired tetralinoleoyl-CL formation on heart and mitochondrial function. In Acsl1
T-/-hearts, normalizing the amount of linoleate present in CL did not improve respiratory dysfunction.
Similarly in S. cerevisiae, CL remodeling can be inhibited without impairing basal or ADP-stimulated mitochondrial O2 consumption (25, 26) . Thus, in both yeast and in Acsl1 T-/-hearts, when total CL content is normal, mitochondrial function appears to be independent of the presence of a specific CL species. In contrast, hearts from tafazzin-deficient mice and from people with Barth's syndrome contain both an increased content of MLCL and a reduction in total CL (8, 41, 42) . These CL changes are associated with a dilated cardiomyopathy, cardiac respiratory dysfunction, and heart failure (43) . Despite the presence of mitochondrial dysfunction, Acsl1 T-/-mice do not develop heart failure, suggesting that when total CL abundance is normal, the absence of a high content of tetralinoleoyl-CL is not physiologically harmful. It will be important to determine whether the Acsl1 T-/-hearts are more susceptible to impaired function when subjected to pressure overload. Conversely, normalizing tetralinoleoyl-CL in Acsl1 T-/-hearts was not sufficient to improve mitochondrial respiratory function. Our data, together with the published yeast studies (25, 26) , suggest that the underlying difficulty in Barth syndrome and tafazzin-deficient mice is a deficiency in CL content and/or the accumulation of MLCL. Mitochondrial respiratory function was measured in isolated mitochondria using a Seahorse XF24
Analyzer, which sequentially injected ADP, oligomycin, FCCP, and antimycin A (n=4-7). O2 consumption rate: OCR. *, p-value ≤0.05 between genotypes within diet. #, p-value ≤0.05 between diets within genotype.
